Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Giessen – page 8

248 clinical trials in Giessen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Giessen at a glance
248
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

248 trials in Giessen

Open in trial search

Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Zilovertamab Vedotin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Nephroblastoma

Recruiting

Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Study comparing Custodiol-N and Custodiol organ preservation solutions for heart transplantation in children

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Alanine
  • Sponsor:Dr. Franz Koehler Chemie GmbH

Study of Narsoplimab for Children with High-Risk Blood Vessel Damage After Stem Cell Transplant

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Narsoplimab
  • Sponsor:Omeros Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carbamazepine
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Study on the Safety and Effects of Cipaglucosidase Alfa and Miglustat for Children with Infantile-onset Pompe Disease

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cipaglucosidase Alfa
  • Sponsor:Amicus Therapeutics Inc.

B-cell lymphoma+1

Recruiting

Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin's Lymphoma and Chronic Graft Versus Host Disease

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Janssen Cilag International

Study on the Safety and Effectiveness of Zipalertinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with Specific EGFR Mutations

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Digoxin
  • Sponsor:Taiho Oncology Inc.

Study on Lowering INR to Reduce Bleeding in Patients with Mechanical Aortic Valves Using Warfarin, Acenocoumarol, and Phenprocoumon

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Hamilton Health Sciences Corporation

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Giessen

What the registry says about research in the country

01 Respiratory Disease Research

Innovative trials focusing on pulmonary hypertension and lung cancer treatments, including evaluation of novel therapies for various stages of NSCLC and rare pulmonary conditions.

  • Pulmonary Arterial Hypertension
  • Non-Small Cell Lung Cancer
  • Idiopathic Pulmonary Fibrosis

Multiple studies are investigating targeted therapies and combination treatments for advanced lung diseases.

02 Rare Disease Studies

Comprehensive research into rare genetic conditions, including Leber congenital amaurosis and Niemann-Pick disease, with trials testing innovative therapeutic approaches.

  • Ataxia Telangiectasia
  • Spinal Muscular Atrophy
  • Hunter Syndrome

These studies aim to improve treatment options for patients with rare genetic disorders.

03 Oncology Research

Advanced clinical trials examining new treatments for various cancers, particularly focusing on head and neck cancer and innovative immunotherapy combinations.

  • Metastatic Lung Cancer
  • Ovarian Cancer
  • Squamous Cell Carcinoma

Studies are evaluating novel drug combinations and targeted therapies for better treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.